Oct 19 (Reuters) – GSK plc: * GSK PLC – JEMPERLI APPROVED IN MSI-H/DMMR RECTAL CANCER * GSK – NO DISEASE RECURRENCES REPORTED AMONG RESPONDERS AFTER TWO-YEAR MEDIAN FOLLOW UP * GSK – FDA APPROVES
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Adds quote from Wilcox in paragraphs 6-7) * Congress provided tenure protections for NLRB members…
VIDEO SHOWS: PARIS ST GERMAIN HOLD PRESS CONFERENCE A DAY AHEAD OF FACING BARCELONA IN…
Oct 19 (Reuters) - CNN chief international anchor Christiane Amanpour will leave next year, after…
By Raphael Satter WASHINGTON, Oct 19 (Reuters) - Two Serbian opposition figures were recently targeted…
INTESA SANPAOLO SPA - SHARES SUBJECT TO THE OFFER COULD BE INCREASED BY A MAXIMUM…
Oct 19 (Reuters) - Walmart Inc.: * WALMART INC FILES FOR FOUR-PART CANADIAN DOLLAR DENOMINATED…